Overview

Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome

Status:
Completed

Trial end date:
2023-08-01

Target enrollment:

Participant gender:

Summary

This study will help us to compare atorvastatin and rosuvastatin in terms of their ability to reduce biomarkers of inflammation in patients of acute coronary syndrome

Phase:

Phase 4

Details

Lead Sponsor:

Rawalpindi Medical College

Treatments:

Atorvastatin
Rosuvastatin Calcium